text: Merck stops \$2.5 bn painkiller Those taking Vioxx are twice as prone to cardiac problems than patients taking a placebo. Shares in Merck, the US pharmaceuticals giant, plunged by 27 per cent yesterday after the company withdrew Vioxx, its 